Amgen Ventures and Alexandria Real Estate Equities have invested $6m in GNS Healthcare, which already counts Celgene, Cambia Health and Mitsui as investors.
US-based precision medicine platform developer GNS Healthcare has raised $6m from Amgen Ventures, the corporate venturing vehicle for pharmaceutical company Amgen, and life sciences real estate trust Alexandria Real Estate Equities.
GNS is developing a machine learning and simulation platform that will be able to be used in drug discovery and development as well as healthcare management and business optimisation for health systems.
The company’s last funding had consisted of $4m provided by undisclosed investors in November 2016, according to…
